A1160: PROpel: Efficacy of abiraterone + olaparib vs. abiraterone + placebo in the first-line treatment of patients with asymptomatic/mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) at baseline

Prof. N.W. (Noel William) Clarke

Clarke N.W.¹, Armstrong A.J.², Thiery-Vuillemin A.³, Oya M.⁴, Shore N.⁵, Procopio G.⁶, Guedes J.D.⁷, Arslan C.⁸, Mehra N.⁹, Parnis F.¹⁰, Brown E.¹¹, Schlürmann F.¹², Joung J.Y.¹³, Sugimoto M.¹⁴, Sartor O.¹⁵, Poehlein C.¹⁶, Barker L.¹⁷, Degboe A.¹⁸, Saad F.¹⁹

¹The Christie and Salford Royal NHS Foundation Trusts, Dept. of Urology, Manchester, United Kingdom, ²Duke Cancer Institute Center for Prostate and Urologic Cancer, Dept. of Medicine, Durham, United States of America, ³CHRU Besançon Hôpital J Minjoz, Medical Oncology Unit, Besançon, France, ⁴Keio University School of Medicine, Dept. of Urology, Tokyo, Japan, ⁵Carolina Urologic Research Center, Dept. of Surgery and Oncology, Myrtle Beach, United States of America, ⁶Istituto Nazionale Tumori Milano, Dept. of Medical Oncology, Milan, Italy, ⁷Hospital de Base de São José do Rio Preto, Dept. of Clinical Oncology, São José do Rio Preto, Brazil, ⁸Izmir Economy University Medical Park Hospital, Dept. of Medical Oncology, Karsiyaka, Turkey, ⁹Radboud University Medical Center, Dept. of Medical Oncology, Nijmegen, The Netherlands, ¹⁰Ashford Cancer Centre Research, Dept. of Medical Oncology, Kurralta Park, Australia, ¹¹University Hospital Southampton, Dept. of Medical Oncology, Southampton, United Kingdom, ¹²Centre Hospitalier de Cornouaille, Dept. of Medical Oncology, Quimper, France, ¹³National Cancer Center, Center For Urological Cancer, Goyang-si, South Korea, ¹⁴Kagawa University Hospital, Dept. of Urology, Kagawa, Japan, ¹⁵Tulane Cancer Center, Dept. of Hematology/Oncology, New Orleans, United States of America, ¹⁶Merck & Co., Inc., Clinical Research Oncology, Rahway, United States of America, ¹⁷AstraZeneca, Global Medicines Development, Oncology R&D, Cambridge, United Kingdom, ¹⁸AstraZeneca, Global Medicines Development, Oncology R&D, Gaithersburg, United States of America, ¹⁹Centre Hospitalier de l’Université de Montréal, CRCHUM, Université de Montreal, Dept. of Urology, Montreal, Canada